Products for Research Use Only
RegisterLogin

(S) -VQW-765

CAT: 0804-HY-19490A-01Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-19490A-01Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
(S) -VQW-765 ((S) -AQW-051) is an orally active, selective and effective α7 nicotinic ACh receptor (nAChR) partial agonist. (S) -VQW-765 has potential applications in cognitive disorders related to neurological diseases, such as Alzheimer's disease or schizophrenia[1][2].
Product Name Alternative
(S) -AQW-051
UNSPSC
12352005
Target
NAChR
Type
Reference compound
Related Pathways
Membrane Transporter/Ion Channel; Neuronal Signaling
Applications
Neuroscience-Neurodegeneration
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/s-vqw-765.html
Purity
98.00
Solubility
10 mM in DMSO
Smiles
CC(C=C1)=CC=C1C2=NC=C(C=C2)O[C@H]3C4CCN(CC4)C3
Molecular Formula
C19H22N2O
Molecular Weight
294.39
References & Citations
[1]Feuerbach D, et al. AQW051, a novel, potent and selective α7 nicotinic ACh receptor partial agonist: pharmacological characterization and phase I evaluation. Br J Pharmacol. 2015 Mar;172 (5) :1292-304. |[2]Mazurov A, et al. Nicotinic acetylcholine receptor modulators[J]. Small Molecule Therapeutics for Schizophrenia, 2015: 213-253.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture)
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-19490-01VQW-765
HY-W953325CRBN ligand-765
HY-RI02411A-01Hsa-miR-765 antagomir
HY-R02411-01Hsa-miR-765 mimic
HY-RI02411-01Hsa-miR-765 inhibitor
HY-R02411A-01Hsa-miR-765 agomir
HY-125845B(S, S, S) -AHPC
HY-120217A(S, S, S) -VH032
HY-172298(R, S, S, S) -Orlistat
HY-112078B(S, S, S) -AHPC-Me

Alternative Products

CatalogName
BA6812-50VQW-765
MBS5815274(S)-VQW-765
GTR19212428-01(S) -VQW-765
2781-25VX-765
MBS132166-01XL 765
7143/50VX 765
MBS5778703UCM 765

Popular Products